IPO Trending
MONOPHARMASME / NSEListed

Mono Pharmacare Limited

Incorporated in 1994, Mono Pharmacare Limited is engaged in the marketing and distribution of pharmaceutical products, offering a wide range of medicines and healthcare items including antibiotics, allergy & cough medicines, antifungals, nutraceuticals, pain relievers, antacids, antiemetics, and cardiac-diabetic medicines, along with cosmocare products. The company sells products under its brand “DLS Export”, which it acquired in 2022 for ₹609 lakhs to expand its product portfolio. As of February 28, 2023, Mono Pharmacare works with more than 168 pharmaceutical distributors & stockists and serves over 3,036 customers across retail pharmacy stores and wholesalers.

₹26 - ₹2813.47x sub
Listed Price29.00
Listing Gain+3.57%
TimelineBook Built Issue IPO
Open28 Aug 2023
Close30 Aug 2023
Allotment04 Sep 2023
Listing07 Sep 2023

Quota Reservation Portions

RetailPortion: 22,64,000 shares
42.72%
Nii(hni)Portion: 22,60,000 shares
42.64%
QIBPortion: 5,00,000 shares
9.43%
Market MakerPortion: 2,76,000 shares
5.21%

Minimum Application Bracket Matrix

Retail1 lots / 4,000 shares
₹1,12,000
HNI2 lots / 8,000 shares
₹2,24,000

About the Company

Incorporated in 1994, Mono Pharmacare Limited is engaged in the marketing and distribution of pharmaceutical products, offering a wide range of medicines and healthcare items including antibiotics, allergy & cough medicines, antifungals, nutraceuticals, pain relievers, antacids, antiemetics, and cardiac-diabetic medicines, along with cosmocare products. The company sells products under its brand “DLS Export”, which it acquired in 2022 for ₹609 lakhs to expand its product portfolio. As of February 28, 2023, Mono Pharmacare works with more than 168 pharmaceutical distributors & stockists and serves over 3,036 customers across retail pharmacy stores and wholesalers.

Company Promoters

Panilam LakhatariyaSupal Lakhatariya